Pen injectors Insulins

Lilly

m HumaPen Luxura HD

m HumaPen Savvio

m Humalog KwikPen (prefill)

m Humalog 200 units/mL KwikPen (prefill)

m Humalog Mix25 KwikPen (prefill)

m Humalog Mix50 KwikPen (prefill)

m Humulin N KwikPen (prefill)

m Basaglar KwikPen (prefill)

Nov

o N

ordi

sk C

anad

a In

c.

m NovoPen Echo

m NovoPen 4

m NovoPen 5

m Fiasp FlexTouch (prefill)

m NovoRapid FlexTouch (prefill)

m Levemir FlexTouch (prefill)

NovoTwist needles are only designed for Novo Nordisk pen devices.

sano

fi-av

enti

s Ca

nada

Inc.

m JuniorSTAR

m ClikSTAR

m Apidra SoloSTAR (prefill)

m Lantus SoloSTAR (prefill)

m Toujeo 300 units/mL SoloSTAR (prefill)

m Others:

Note: Check the product monograph for the type of needle that can be used with the pen injector selected.

• Use shorter needles of 4 mm, 5 mm or 6mm. They are suitable for all people with diabetes, regardless of body mass index (BMI).• The use of 4 mm pen needles avoids the risk of intramuscular injection.• Structured rotation of anatomical area and injection site avoids lipohypertrophy.

m Humalog (lispro)

m Humulin R

m Humulin 30/70

m Humalog Mix25

m Humalog Mix50

m Humulin N

m Basaglar (glargine)

m Fiasp (faster aspart)

m NovoRapid (aspart)

m Novolin ge Toronto

m Novolin ge NPH

m Novolin ge 30/70

m Novolin ge 40/60

m Novolin ge 50/50

m NovoMix 30

m Levemir (detemir)

m Apidra (glulisine)

m Lantus (glargine)

Suggested document: FIT Canada-Forum for Injection Technique Canada - Recommendation for best practice in injection techniques - 3rd edition 2017 - www.fit4diabetes.com

Realisation: Médecine de jour métabolique de l’Hôtel-Dieu du CHUM -Françoise Desrochers, nurse clinician, diabetes educator, CHUM.

Isabelle Schmidt, graphist/Marcel La Haye, photographer.

Understand Your Treatment...and Live a Healthy Life!

Insulins

This documenT was produced Through financial supporT by 5nd edition, 2017/07

Realisation: Médecine de jour métabolique de l’Hôtel-Dieu du CHUM -Françoise Desrochers, nurse clinician, diabetes educator, CHUM.

Isabelle Schmidt, graphist/Marcel La Haye, photographer.

Understand Your Treatment...and Live a Healthy Life!

Antidiabetic drugs other than insulins

This documenT was produced Through financial supporT by 5nd edition, 2017/07

Class Drugs Brand name(non-exhaustive list)

Commercialpresentation

Risk ofhypoglycemia

Glucagon-like peptide 1 (GLP-1) receptor agonists

- long-actingDulaglutide - long-acting Trulicity

0.75 mg/0,5 ml

1.5 mg/0,5 mlOnce weekly; single dose pen

No

Glucagon-LikePeptide-1 (GLP-1)receptor agonists

Exenatide Byetta5 µg per dose (1 x 1.2mL - 60 doses)

10 µg per dose (1 x 2.4mL - 60 doses)

No

Glucagon-like peptide 1 (GLP-1) receptor agonists

- long-acting

Exenatide for extended-release

injectable suspension

Bydureon2 mg/dose

Once weekly; single dose pen

No

Glucagon-LikePeptide-1 (GLP-1)receptor agonists

Liraglutide Victoza6mg/mL

(1 X 3mL - doses of 0.6mg, 1.2mg, 1.8mg)

No

Glucagon-like peptide 1 (GLP-1) receptor agonists Lixisenatide Adlyxine

Prefill pen of 10 µg per dose (0.05 mg/mL - 14 doses)

Prefill pen of 20 µg per dose (0.1 mg/mL- 14 doses)

No

m

m

m

m

m

m

Suggested document: FIT Canada-Forum for Injection Technique Canada - Recommendation for best practice in injection techniques - 3rd edition 2017 - www.fit4diabetes.com

Hypoglycemia:

Blood sugar below 4.0 mmol/LImmediately eat 15 g of fast acting carbohydrates Wait 15 minutes and repeat if necessary

References: Nathan DM. and al. Diabetes Care 2008:31:1473-1478

Realisation: Médecine de jour métabolique de l’Hôtel-Dieu du CHUM - Françoise Desrochers, nurse clinician, diabetes educator, CHUM1st edition 2008: Paméla C. Gariépy, cartoonist; and Jean-Charles Marier, graphist - 2nd edition 2014: Isabelle Schmidt, graphist

Glycosylated hemoglobin (A1C)

Shows the control of diabetes in the last two to three months